MRKR Market Cap History
Below is a table of the MRKR market cap history going back to 8/2/2018:

Date MRKR Market Cap

Also see: MRKR Shares Outstanding History
and MRKR YTD Return
MRKR Historical Market Cap:
-23.14% CAGR
MRKR Historical Market Cap: +-23.14% CAGR

Mouse over chart for data details
8/2/2018 ...11/1/2022
Marker Therapeutics is a clinical-stage immuno-oncology company focusing on the development of T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Co. is developing three product candidates as part of its multi tumor associated antigen-specific T cell program for: autologous treatment of lymphoma, and selected solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia (AML); and off-the-shelf products in various indications. Co.'s clinical development programs are: MT-401 for the treatment of post-transplant AML; MT-401-OTS for the treatment of AML; and MT-601 for the treatment of lymphoma. We show 16 historical shares outstanding datapoints in our MRKR shares outstanding history coverage, used to compute MRKR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MRKR market cap history over the course of time is important for investors interested in comparing MRKR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MRKR versus a peer is one thing; comparing MRKR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MRKR can fluctuate over the course of history. With this page we aim to empower investors researching MRKR by allowing them to research the MRKR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree MRKR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Marker Therapeutics (MRKR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

MRNA Market Cap History
MRNS Market Cap History
MRSN Market Cap History
MRTX Market Cap History
MRVI Market Cap History
MSON Market Cap History
MTCR Market Cap History
MTEM Market Cap History
MXCT Market Cap History
MYGN Market Cap History
More Healthcare companies »


MRKR Market Cap History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.